GLP-1 Alzheimer’s: A New Frontier in Neurodegenerative Disease Treatment
Recent breakthroughs in medical research have opened new doors in the treatment of Alzheimer’s disease, and one promising development is the potential role of GLP-1 Alzheimer’s therapy. Originally developed for type 2 diabetes and weight loss, GLP-1 receptor agonists are now being explored for their neuroprotective properties. This article delves into how GLP-1 drugs may…
